英文論文寫作標(biāo)題市公開(kāi)課金獎(jiǎng)市賽課一等獎(jiǎng)?wù)n件

ContactUs

asevana@

QQ:84749946HowtoPreparetheTITLETECH&BELIEF第1頁(yè)第1頁(yè)TECH&BELIEFContactUs

asevana@

QQ:84749946Thetitlewillbereadbythousandsofpeople.Perhapsfewpeoplewillreadtheentirepaper.Animproperlytitledpapermaybevirtuallylostandneverreachitsintendedaudience.第2頁(yè)第2頁(yè)TECH&BELIEFContactUs

asevana@

QQ:84749946LengthSpecificSyntaxAbbreviations&JargonSeriesTitles&HangingTitle第3頁(yè)第3頁(yè)TECH&BELIEFContactUs

asevana@

QQ:84749946LengthoftheTitleTooshort&Toolong第4頁(yè)第4頁(yè)TECH&BELIEFContactUs

asevana@

QQ:84749946Tooshort

"StudiesonBrucella"“Study”：分類學(xué)，遺傳學(xué)，生物化學(xué)，還是醫(yī)學(xué)？第5頁(yè)第5頁(yè)TECH&BELIEFContactUs

asevana@

QQ:84749946Toolong

"Ontheadditiontothemethodofmicroscopicresearchbyanewwayofproducingcolour-contrastbetweenanobjectanditsbackgoundorbetweendefinitepartsoftheobjectitself"標(biāo)題太過(guò)冗長(zhǎng)，沒(méi)有提供足量信息，也沒(méi)有專業(yè)術(shù)語(yǔ)。與其說(shuō)是標(biāo)題，不如說(shuō)是摘要，但遺憾是，也不是一篇好摘要第6頁(yè)第6頁(yè)TECH&BELIEFContactUs

asevana@

QQ:84749946標(biāo)題適宜長(zhǎng)度：普通論文普通為10～15個(gè)中文或12～22個(gè)英文單詞，學(xué)位論文可稍長(zhǎng)一些。美國(guó)《新英格蘭醫(yī)學(xué)雜志》在稿約中要求：“必要時(shí)給目錄寫一個(gè)限制在75個(gè)字母之間短題”。若能用1行文字表示，就盡量不要用2行（超出2行有也許會(huì)削弱讀者印象）第7頁(yè)第7頁(yè)TECH&BELIEFContactUs

asevana@

QQ:84749946Wasteword:無(wú)用、多出起首語(yǔ)A…An…The…Studyon…Researchon…Observationon…Investigationon…第8頁(yè)第8頁(yè)TECH&BELIEFContactUs

asevana@

QQ:84749946ANovelImmunoregulatoryFunctionforIL-23:InhibitionofIL-12DependentIFN-γProductionTheeffectsofgroup1versusgroup2carbapenemsonimipenem-resistantPseudomonasaeruginosa:anecologicalstudy第9頁(yè)第9頁(yè)TECH&BELIEFContactUs

asevana@

QQ:84749946DiscussiononSeveralAcademicProblemsintheBookTheModernHistoryofChinesePaperMoney

《中國(guó)近代紙幣史》中幾種學(xué)術(shù)問(wèn)題探討。SeveralQuestionsinModernHistoryofChineseBanknotes

第10頁(yè)第10頁(yè)TECH&BELIEFContactUs

asevana@

QQ:84749946Mosttitlesthataretooshortbecausetheyincludegeneralratherthanspecificterms.第11頁(yè)第11頁(yè)TECH&BELIEFContactUs

asevana@

QQ:84749946NeedforSpecificTitles“Action

ofAntibioticson

Bacteria”Bacteria:

Mycobacteriumtuberculosis,gram-positivebacteria,Plant-PathogenicBacteria;Antibiotics:Streptomycin,VariousAntifungalAntibiotics;Action:InhibitionofGrowth.

第12頁(yè)第12頁(yè)TECH&BELIEFContactUs

asevana@

QQ:84749946為確保題名含義準(zhǔn)確，應(yīng)盡也許避免使用非定量、含義不明詞，如"rapid"，"new"等；并力爭(zhēng)用詞含有專指性，恰當(dāng)反應(yīng)所研究范圍和深度。SuccinationofKeap1andActivationofNrf2-DependentAntioxidantPathwaysinFH-De?cientPapillaryRenalCellCarcinomaType2.（這里專指二型）AndrogenReceptorGeneExpressioninProstateCancerisDirectly（直接克制，準(zhǔn)確性）SuppressedbytheAndrogenReceptorThroughRecruitmentofLysine-Speci?cDemethylase1第13頁(yè)第13頁(yè)TECH&BELIEFContactUs

asevana@

QQ:84749946ImportanceofSyntax標(biāo)題結(jié)構(gòu)用詞特點(diǎn)詞序問(wèn)題第14頁(yè)第14頁(yè)TECH&BELIEFContactUs

asevana@

QQ:84749946學(xué)術(shù)文章標(biāo)題主要有三種結(jié)構(gòu)：名詞性標(biāo)題(包括動(dòng)名詞)介詞性標(biāo)題名詞+介詞性標(biāo)題第15頁(yè)第15頁(yè)TECH&BELIEFContactUs

asevana@

QQ:84749946名詞詞組（包括動(dòng)名詞）Bypass,circulatoryarrest,andpulmonaryendarterectomy介詞詞組Towardsriskreductioninnon-cardiacsurgery名詞詞組+介詞詞組InVivoIdentificationofTumor-SuppressivePTENceRNAsinanOncogenicBRAF-InducedMouseModelofMelanomaInteractionbetweenDifferentiatingCell-andNiche-DerivedSignalsinHematopoieticProgenitorMaintenance第16頁(yè)第16頁(yè)TECH&BELIEFContactUs

asevana@

QQ:84749946標(biāo)題中較少出現(xiàn)動(dòng)詞，假如出現(xiàn)動(dòng)詞也多為分詞、動(dòng)名詞形式。ALargeIntergenicNoncodingRNAInduced（過(guò)去分詞）byp53MediatesGlobalGeneRepressioninthep53Response.Virus-inducedgenesilencing（動(dòng)名詞）inplants第17頁(yè)第17頁(yè)TECH&BELIEFContactUs

asevana@

QQ:84749946Thetitleofapaperisalabel.Itnormallyisnotasentence.由于題名比句子簡(jiǎn)短,并且無(wú)需主、謂、賓,因此詞序就也變得尤為主要。假如詞語(yǔ)間修飾關(guān)系使用不妥,就會(huì)影響讀者正確理解題名真實(shí)含意。Faultywordorder第18頁(yè)第18頁(yè)TECH&BELIEFContactUs

asevana@

QQ:84749946Carsblamedforpollutionbyscientist科學(xué)家造成污染歸罪于汽車Carsblamedbyscientistforpollution科學(xué)家將污染歸罪于汽車

早起肝癌切除術(shù)Factorsinfluencingprimarylivercancer

resectionsurvivalrate.這種簡(jiǎn)樸名詞堆砌很容易引起歧義Factorsinfluencingsurvivalrateafterresectionofprimarylivercancer.第19頁(yè)第19頁(yè)TECH&BELIEFContactUs

asevana@

QQ:84749946在題名中使用垂懸分詞（如using等）時(shí)應(yīng)十分小心。其潛在主語(yǔ)應(yīng)是研究者,而不是研究對(duì)象。Isolationofantigensfrommonkeys

usingcomplement-fixationtechniques.猴子使用了補(bǔ)體結(jié)合技術(shù)。Usingcomplement-fixationtechniquesinisolationofantigensfrommonkeys。利用補(bǔ)體結(jié)合技術(shù)分離猴抗原。第20頁(yè)第20頁(yè)TECH&BELIEFContactUs

asevana@

QQ:84749946DeterminationofBupropion（安非他酮）UsingLiquidChromatographywithFluorescenceDetectioninPharmaceuticalPreparations,HumanPlasmaandHumanUrineUsingrealoptionstocomparetheeconomicsofnuclearpowerandwindpowerwithelectricityfromnaturalgas第21頁(yè)第21頁(yè)TECH&BELIEFContactUs

asevana@

QQ:84749946Assertivesentencetitle必定句題目

is

會(huì)展示強(qiáng)烈主張。Thep21Cdk-interactingproteinCip1isapotentinhibitorofG1cyclin-dependentkinasesp21Cdk作用蛋白是G1細(xì)胞周期依賴性蛋白激酶強(qiáng)克制劑。Cell199375(4):805-816被引3247次.第22頁(yè)第22頁(yè)TECH&BELIEFContactUs

asevana@

QQ:84749946題目應(yīng)當(dāng)能夠反應(yīng)出文章所闡述側(cè)重點(diǎn)：Validationandcomparisonofmodelstopredictnon-sentinellymphnodemetastasisinbreastcancerpatients.側(cè)重于表明研究目的和內(nèi)容研究結(jié)論第23頁(yè)第23頁(yè)TECH&BELIEFContactUs

asevana@

QQ:84749946研究對(duì)象、內(nèi)容、辦法第24頁(yè)第24頁(yè)TECH&BELIEFContactUs

asevana@

QQ:84749946Abbreviations&JargonTitlesshouldalmostnevercontainabbreviations,chemicalformulas,proprietary(ratherthangeneric)names,jargon,andthelike.第25頁(yè)第25頁(yè)TECH&BELIEFContactUs

asevana@

QQ:84749946第26頁(yè)第26頁(yè)TECH&BELIEFContactUs

asevana@

QQ:84749946假設(shè)：在一個(gè)新概念產(chǎn)生早期，文章標(biāo)題傾向于用全稱。伴隨概念普及，在標(biāo)題中使用縮略語(yǔ)百分比會(huì)上升。第27頁(yè)第27頁(yè)TECH&BELIEFContactUs

asevana@

QQ:847499461991199319951996total111131ZincFingerNuclease111131ZFN000000total12613207ZincFingerNuclease12512194ZFN001113第28頁(yè)第28頁(yè)TECH&BELIEFContactUs

asevana@

QQ:84749946第29頁(yè)第29頁(yè)TECH&BELIEFContactUs

asevana@

QQ:84749946TargetedgeneadditiontoapredeterminedsiteinthehumangenomeusingaZFN-basednickingenzyme.AZFN/piggyBacstepclosertoautologouslivercelltherapy.HER2+BreastCancerTherapy:ByCPP-ZFNMediatedTargetingofmTOR?PositiveresultswithautologoustransplantofZFN-modifiedCD4T-cells:asteptowardapractical,functionalcureforHIV.第30頁(yè)第30頁(yè)TECH&BELIEFContactUs

asevana@

QQ:84749946HangingTitle內(nèi)容層次諸多情況下，假如難以簡(jiǎn)短化，最好采用主、副題名相結(jié)合辦法，副題名起補(bǔ)充、闡明作用，可起到較好效果。Importanceofreplicationinmicroarraygeneexpressionstudies:statisticalmethodsandevidencefromrepet